ACADIA Pharmaceuticals Inc. (ACAD) ownership: insiders 23% · institutions 91% · index and ETF funds 7% (13F 2026-03-31). Insider activity, 90 days: 8 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Baker BROS. Advisors LP | 42896690.00 | $954.88M | 25.1% | 2026-03-31 |
| BlackRock | 21550921.00 | $479.72M | 12.6% | 2026-03-31 |
| Vanguard | 15413542.00 | $343.11M | 9.0% | 2026-03-31 |
| State Street | 8332771.00 | $185.49M | 4.9% | 2026-03-31 |
| RTW Investments, LP | 7144524.00 | $159.04M | 4.2% | 2026-03-31 |
| Geode Capital Management | 3464689.00 | $77.14M | 2.0% | 2026-03-31 |
| First Trust Advisors LP | 3343868.00 | $74.43M | 2.0% | 2026-03-31 |
| Dimensional Fund Advisors | 3155160.00 | $70.22M | 1.8% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-08-05 | |
| Sell | null | 2026-07-29 |
Back to ACAD overview · ACAD earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.